Innovation

Mycobacterial Vaccine Vectors and Methods of Using the Same (BIDMC 1201)

Beth Israel Deaconess Medical Center
posted on 01/12/2012

These monoclonal antibodies inhibit FcεRI-mediated mast cell degranulation both in vitro and in vivo.


Innovation Details
 

File Number: 807 

Other Information:

Investigator(s)
Dr. Norman Letvin

Contact
Stanley, Mah C


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Beth Israel Deaconess Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...